Top Quality Rivaroxaban Powder with Best Price CAS 366789-02-8

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: TGY-2023051202
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Product Name: Rivaroxaban
• Sample: Avaliable
• Appearance: White Powder
• Shelf Life: 2 Years
• MOQ: 1kg
• Type: API
• Formula: C21h21n3o5
• Einecs: 610-200-5
• Molecular Weight: 395.41
• Storage: Normal
• Transport Package: 1kg/Foil Bag 25kg/Drum
• Specification: HPLC 99%
• Trademark: TGY
• Origin: Xi′an, Shaanxi, China
• HS Code: 3004909099
• Production Capacity: 6500kg/Month

Product Description

Rivaroxaban is an oral anticoagulant. It is an orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects lasts 8 to 12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
There is currently no specific way to reverse the anticoagulant effect of rivaroxaban in the event of a major bleeding event, unlike warfar in.

Product Name	Rivaroxaban intermediates
CAS NO.	446292-07-5
Appearance	White powder
Purity	99%
Boiling point	734.9±60.0 °C(Predicted)
Density	1.421
Application	Pharmaceutical intermediates; Rivaroxaban intermediates; Pharmaceutical raw materials; Chemical intermediates
Chemical structure
Usage	Rivaroxaban intermediates
Storage	Normal Temperature

1.Rivaroxaban can be used to prevent strokes in those with atrial fibrillation due to causes other than heart valvedisease, and at least one additional risk factor for stroke (congestive heart failure, hypertension, age, diabetes, and prior stroke).
2.Rivaroxaban can also be used to prevent the formation of blood clots in the veins (deep venous thrombosis) in adults who have had an operation to replace a hip or knee and for treatment and prevention of acute deep venous thrombosis in adults. It can not be used for prevention of venous thrombosis in hospitalized medically ill patients.
3.Rivaroxaban is not indicated for prosthetic heart valves or for mitral stenosis.
 
Rivaroxaban is an oral anticoagulant. It is an orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects lasts 8 to 12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.
There is currently no specific way to reverse the anticoagulant effect of rivaroxaban in the event of a major bleeding event.